Table 1.
No. | Compound | Activity | Reference |
---|---|---|---|
1 | Quinine | Anti-tumor activity | 93 |
Antimalarial activity | 2,3,166,167 | ||
Trypanocidal activity | 108 | ||
2 | Camptothecin | Anti-tumor activity | 6,60–64 |
3 | Vasicine | Antifeedant activity | 215 |
Cardiovascular protective activity | 281 | ||
Bronchodilator activity | 332 | ||
Oxytocic activity | 340 | ||
4 | Febrifugine | Antimalarial activity | 176–186 |
Trypanocidal activity | 219 | ||
28 | Quinidine | Anti-tumor activity | 91,92 |
Antiarrhythmic activity | 256–266 | ||
Effect on CYP3A4 | 323 | ||
29 | Zanthosimuline | Anti-tumor activity | 94 |
30 | Huajiaosimuline | Anti-tumor activity | 94,95 |
Antiplatelet activity | 95 | ||
31 | Flindersine | Anti-tumor activity | 96,97 |
Anti-bacterial activity | 228 | ||
Anti-fungal activity | 244 | ||
SRS-A antagonist | 333 | ||
32 | Haplamine | Anti-tumor activity | 97 |
Anti-fungal activity | 244 | ||
33 | γ-Fagarine | Anti-tumor activity | 100,121 |
Antiplatelet activity | 95 | ||
Cardiovascular protective activity | 275 | ||
Anti-HIV activity | 284 | ||
Mutagenicity | 336 | ||
Estrogenic activity | 341 | ||
34 | Skimmianine | Anti-tumor activity | 98,100 |
Antimalarial activity | 173 | ||
Anti-leishmania activity | 199 | ||
Trypanocidal activity | 200 | ||
Anti-bacterial activity | 228 | ||
Anti-fungal activity | 245 | ||
Antiplatelet activity | 95,269–272 | ||
Cardiovascular protective activity | 273,275 | ||
Antagonists at the 5-HT2 receptor site | 307 | ||
Mutagenicity | 335 | ||
Estrogenic activity | 341 | ||
35 | Haplopine | Anti-tumor activity | 97 |
Antimalarial activity | 173 | ||
Anti-bacterial activity | 228 | ||
Antiplatelet activity | 95 | ||
Cardiovascular protective activity | 275 | ||
Anti-HIV activity | 284 | ||
Estrogenic activity | 341 | ||
36 | Evolitrine | Anti-tumor activity | 98 |
Antifeedant activity | 201 | ||
Antiplatelet activity | 269–272 | ||
Cardiovascular protective activity | 275 | ||
Antiviral activity | 292 | ||
Anti-inflammatory activity | 293 | ||
37 | Kokusaginine | Anti-tumor activity | 98 |
Antimalarial activity | 173 | ||
Trypanocidal activity | 200 | ||
Insecticidal activity | 203,204 | ||
Anti-bacterial activity | 228 | ||
Anti-fungal activity | 245 | ||
Antiplatelet activity | 269–272 | ||
Cardiovascular protective activity | 275 | ||
Antagonists at the 5-HT2 receptor site | 307 | ||
38 | Maculosidine | Anti-tumor activity | 98 |
39 | 2,3-Methylenedioxy-4,7-dimethoxyquinoline | Anti-tumor activity | 98 |
40 | Dictamnine | Anti-tumor activity | 99,100 |
Antifeedant activity | 201,202 | ||
Anti-fungal activity | 245,246 | ||
Antiplatelet activity | 267,269–272 | ||
Cardiovascular protective activity | 275 | ||
Antiviral activity | 292 | ||
Mutagenicity | 335 | ||
41 | Graveoline | Anti-tumor activity | 99 |
Herbicidal activity | 314 | ||
42 | Maculine | Anti-tumor activity | 101 |
Anti-fungal activity | 245 | ||
43 | 5-Methoxymaculine | Anti-tumor activity | 101 |
44 | 5,8-Dimethoxymaculine | Anti-tumor activity | 101 |
45 | 4,5,6,7,8-Pentamethoxyfuroquinoline | Anti-tumor activity | 101 |
46 | Flindersiamine | Anti-tumor activity | 101 |
Anti-bacterial activity | 227 | ||
Anti-fungal activity | 245 | ||
47 | 7-(2′-Hydroxy-3′chloroprenyloxy)-4-methoxy-furoquinoline | Anti-tumor activity | 102 |
48 | 7-(2′,3′-Epoxyprenyloxy)-4-methoxyfuroquinoline | Anti-tumor activity | 102 |
49 | Pteleine | Anti-tumor activity | 103 |
Antiplatelet activity | 269–272 | ||
50 | (+)-7,8-Dimethoxymyrtopsine | Anti-tumor activity | 102,103 |
51 | Medicosmine | Anti-tumor activity | 104 |
52 | Jineol | Anti-tumor activity | 105 |
Anti-oxidant activity | 329 | ||
53 | 3,8-Dimethoxyquinoline | Anti-tumor activity | 105 |
54 | 3,8-Diacetoxyquinoline | Anti-tumor activity | 105 |
55 | Senepodine A | Anti-tumor activity | 106 |
56 | 7-Hydroxy-4-[5′-hydroxymethylfuran-2′-yl]-2-quinolone | Anti-tumor activity | 107 |
57 | Acetylcupreine | Anti-tumor activity | 108 |
Insecticidal activity | 108 | ||
58 | 3,3-Diisopentenyl-N-methyl2,4-quinoldione | Anti-tumor activity | 109 |
59 | Cuspareine | Anti-tumor activity | 110 |
Antimalarial activity | 110 | ||
60 | Galipeine | Anti-tumor activity | 110 |
Antimalarial activity | 110 | ||
61 | Galipinine | Anti-tumor activity | 110 |
Antimalarial activity | 110 | ||
62 | Angustureine | Anti-tumor activity | 110 |
Antimalarial activity | 110 | ||
63 | Asimicilone | Anti-tumor activity | 111 |
64 | Lepadin A | Anti-tumor activity | 112,113 |
65 | Lepadin B | Anti-tumor activity | 112,113 |
66 | Lepadin C | Anti-tumor activity | 112,113 |
67 | Lepadin D | Antimalarial activity | 112,113 |
Trypanocidal activity | 112,113 | ||
Anti-fungal activity | 112,113 | ||
68 | Lepadin E | Anti-tumor activity | 112,113 |
Antimalarial activity | 112,113 | ||
Trypanocidal activity | 112,113 | ||
Anti-fungal activity | 112,113 | ||
69 | Lepadin F | Anti-tumor activity | 112,113 |
Antimalarial activity | 112,113 | ||
Trypanocidal activity | 112,113 | ||
Anti-fungal activity | 112,113 | ||
70 | Lepadin G | Anti-tumor activity | 112,113 |
71 | Benzastatin C | Neuroprotective activity | 114,115 |
Anti-oxidant activity | 114,115 | ||
72 | Benzastatin D | Neuroprotective activity | 114,115 |
Anti-oxidant activity | 114,115 | ||
73 | (−)-SW-163C | Anti-tumor activity | 116,117 |
74 | (−)-SW-163E | Anti-tumor activity | 116,117 |
75 | 3S*,4R*-Dihydroxy-4-(4′methoxyphenyl)-3,4-dihydro-2(1H)-quinolinone | Anti-tumor activity | 118 |
76 | 3R*,4R*-Dihydroxy-4-(4′methoxyphenyl)-3,4-dihydro-2(1H)-quinolinone | Anti-tumor activity | 118 |
77 | Peniprequinolone | Anti-tumor activity | 118 |
Nematicidal activity | 210 | ||
78 | Aspernigerin | Anti-tumor activity | 119 |
79 | (+)-Quinocitrinine A | Anti-tumor activity | 120 |
Anti-bacterial activity | 120 | ||
80 | (−)-Quinocitrinine B | Anti-tumor activity | 120 |
Anti-bacterial activity | 120 | ||
81 | Isodictamnine | Anti-tumor activity | 121 |
82 | Iso-γ-fagarine | Anti-tumor activity | 121 |
83 | Luzopeptin A | Anti-tumor activity | 121–126 |
Anti-HIV activity | 286 | ||
84 | Luzopeptin B | Anti-tumor activity | 121–126 |
Anti-HIV activity | 286 | ||
85 | Luzopeptin C | Anti-tumor activity | 121–126 |
Anti-HIV activity | 286 | ||
86 | Streptonigrin | Anti-tumor activity | 127 |
87 | 7-(1-Methyl-2-oxopropyl)streptonigrin | Anti-tumor activity | 127 |
88 | BE-22179 | Anti-tumor activity | 128,129,132,133 |
89 | Thiocoraline | Anti-tumor activity | 130–133 |
Anti-bacterial activity | 240 | ||
90 | Confusadine | Anti-tumor activity | 134 |
Antiplatelet activity | 274 | ||
91 | Furomegistine I | Anti-tumor activity | 135 |
92 | Furomegistine II | Anti-tumor activity | 135 |
93 | Megistosarconine | Anti-tumor activity | 136 |
94 | Cyclomegistine | Anti-tumor activity | 137 |
95 | 4-Carbomethoxy-6-hydroxy2-quinolone | Anti-tumor activity | 138 |
Anti-oxidant activity | 330 | ||
96 | Viridicatin | Anti-tumor activity | 139 |
97 | Viridicatol | Anti-tumor activity | 139,140 |
98 | Fumiquinazoline A | Anti-tumor activity | 141,142 |
99 | Fumiquinazoline B | Anti-tumor activity | 141,142 |
100 | Fumiquinazoline C | Anti-tumor activity | 141,142 |
101 | Fumiquinazoline D | Anti-tumor activity | 141,142 |
102 | Fumiquinazoline E | Anti-tumor activity | 141,142 |
103 | Fumiquinazoline F | Anti-tumor activity | 141,142 |
104 | Fumiquinazoline G | Anti-tumor activity | 141,142 |
105 | (−)-Spiroquinazoline | Anti-tumor activity | 143 |
106 | Luotonin A | Anti-tumor activity | 144–146 |
107 | Luotonin B | Anti-tumor activity | 144–146 |
108 | Luotonin E | Anti-tumor activity | 144–146 |
109 | Luotonin F | Anti-tumor activity | 144–146 |
110 | Deoxyvasicine | Anti-tumor activity | 148 |
Anticholinesterase activity | 309 | ||
111 | Tryptanthrin | Anti-tumor activity | 152–155 |
Antimalarial activity | 187,188 | ||
Trypanocidal activity | 217 | ||
Antifeedant activity | 216 | ||
Anti-bacterial activity | 253,254 | ||
Anti-inflammatory activity | 298,299 | ||
112 | Qingdainone | Anti-tumor activity | 152 |
113 | 3-(2-Carboxyphenyl)-4(3H)-quinazolinone | Anti-tumor activity | 156 |
114 | 1-Methoxy-7,8-dehydrorutaecarpine | Anti-tumor activity | 157 |
115 | Rutaecarpine | Anti-tumor activity | 157 |
Antiplatelet activity | 277 | ||
Anti-inflammatory activity | 306 | ||
Effect on CYP1A1, CYP1A2 and CYP1B1 | 318–322 | ||
116 | 1-Hydroxyrutaecarpine | Anti-tumor activity | 157 |
Antiplatelet activity | 277 | ||
117 | Samoquasine A | Anti-tumor activity | 158–161 |
118 | 2-Acetyl-4(3H)-quinazolinone | Anti-tumor activity | 162,163 |
Anti-HIV activity | 162,163 | ||
119 | 2-n-Propylquinoline | Antimalarial activity | 172 |
Anti-leishmania activity | 192–196 | ||
Trypanocidal activity | 197 | ||
Molluscicidal activity | 198 | ||
Antiviral activity | 289–291 | ||
120 | 2-Pentylquinoline | Antimalarial activity | 172 |
Anti-leishmania activity | 192–196 | ||
Trypanocidal activity | 197 | ||
Molluscicidal activity | 198 | ||
Antiviral activity | 289–291 | ||
121 | Chimanine B | Antimalarial activity | 172 |
Anti-leishmania activity | 192–195 | ||
122 | Chimanine D | Antimalarial activity | 172 |
Anti-leishmania activity | 192–195 | ||
Antiviral activity | 289–291 | ||
123 | 4-Methoxy-2phenylquinoline | Antimalarial activity | 172 |
124 | 2-(3,4- Methylenedioxyphenylethyl)quinoline | Antimalarial activity | 172 |
Anti-leishmania activity | 192–195 | ||
Molluscicidal activity | 198 | ||
Antiviral activity | 289–291 | ||
125 | Acronycidine | Antimalarial activity | 173 |
126 | Acronydine | Antimalarial activity | 173 |
127 | Veprisine | Antimalarial activity | 174 |
SRS-A antagonists | 333 | ||
128 | N-Methylpreskimmianine | Antimalarial activity | 174 |
129 | 2-Nonyl-4-(1H)-quinolone | Antimalarial activity | 175 |
Immunomodulatory activity | 297 | ||
130 | 2-Undecyl-4-(1H)-quinolone | Antimalarial activity | 175 |
Immunomodulatory activity | 297 | ||
131 | 2-(Undec-1-enyl)quinolin4-(1H)-one | Antimalarial activity | 175 |
132 | Isofebrifugine | Antimalarial activity | 176–186 |
133 | Quinazolin-4-(3H)-one | Antimalarial activity | 181 |
Bronchodilator activity | 331,332 | ||
134 | 2-Methoxyrutaecarpine | Effect on CYP1A1, CYP1A2 and CYP1B1 | 318 |
136 | 5,8,13,14-Tetrahydro-2methoxy-14-methyl-5oxo-7H-indolo[2′,3′:3,4]-pyrido[2,1b] quinazolin-6-ium chloride | Antimalarial activity | 174 |
137 | (−)-Janoxepin | Antimalarial activity | 189 |
138 | Cusparine | Anti-leishmania activity | 199 |
140 | rel-(7R,8R)-8-[(E)-3-hydroxy3-methyl-1-butenyl]-4,8-dimethoxy-5,6,7,8-tetrahydrofuro[2,3-b]quinoline-7-yl acetate | Trypanocidal activity | 200 |
141 | Evocarpine | Insecticidal activity | 204 |
Anti-bacterial activity | 222,223,225 | ||
Cardiovascular protective activity | 276 | ||
Immunomodulatory activity | 297 | ||
Hypolipidaemic activity | 328 | ||
142 | Dihydroevocarpine | Insecticidal activity | 204 |
Anti-bacterial activity | 222 | ||
Immunomodulatory activity | 297 | ||
Hypolipidaemic activity | 328 | ||
143 | Antidesmone | Trypanocidal activity | 205 |
144 | N-Methyl-2-nonylquinolin-4(1H)-one | Trypanocidal activity | 206 |
145 | N-Methyl-2-hexylquinolin-4(1H)-on | Trypanocidal activity | 206 |
146 | Atanine | Antiparasitic and anthelmintic activity | 207 |
147 | Quinolactacide | Insecticidal activity | 208,209 |
148 | Penigequinolone A | Nematicidal activity | 210 |
Herbicidal activity | 315 | ||
149 | Penigequinolone B | Nematicidal activity | 210 |
Herbicidal activity | 315 | ||
150 | 3-Methoxy-4-hydroxy-4-(4′-methoxyphenyl)quinolinone | Nematicidal activity | 210 |
151 | 3-Methoxy-4,6-dihydroxy-4- (4′-methoxyphenyl)quinolinone | Nematicidal activity | 210 |
152 | Leiokinine A | Antifeedant activity | 211 |
153 | Leiokinine A | Antifeedant activity | 211 |
154 | 3,4-Dihydroxyquinoline-2-carboxylic acid | Antifeedant activity | 212 |
155 | (−)-Yaequinolone J1 | Insecticidal activity | 213 |
156 | (−)-Yaequinolone J2 | Insecticidal activity | 213 |
157 | 3-Methoxy-4,5-dihydroxy-4- (4′-methoxyphenyl)quinolinone | Insecticidal activity | 214 |
158 | Vasicinone | Antifeedant activity | 215 |
Bronchodilator activity | 331 | ||
159 | Vasicinol | Antifeedant activity | 215 |
160 | (+)-Nα-Quinaldyl-L-arginine | Antifeedant activity | 218 |
161 | 1,3-Dimethylquinazoline2,4-dione | Insecticidal activity | 220,221 |
162 | 1-Methyl-2-pentadecyl4(1H)-quinolone | Anti-bacterial activity | 222 |
Immunomodulatory activity | 297 | ||
163 | 1-Methyl-2-[(4Z,7Z)-4,7-tridecadienyl]-4(1H)-quinolone | Anti-bacterial activity | 222,225 |
Cardiovascular protective activity | 276 | ||
Immunomodulatory activity | 297 | ||
Hypolipidaemic activity | 328 | ||
164 | 1-Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone | Anti-bacterial activity | 222,225 |
Cardiovascular protective activity | 276 | ||
Immunomodulatory activity | 297 | ||
Hypolipidaemic activity | 328 | ||
165 | 1-Methyl-2-undecyl-4(1H)-quinoline | Anti-bacterial activity | 222,225 |
Immunomodulatory activity | 297 | ||
166 | 1-Methyl-2-[(Z)-7tridecadienyl]-4(1H)-quinolone | Anti-bacterial activity | 223 |
167 | 1-Methyl-2-(6Z)-6undecenyl-quinolone | Anti-bacterial activity | 225 |
168 | 2,3-Dimethyl-4-quinolone | Anti-bacterial activity | 226 |
169 | Megistoquinone I | Anti-bacterial activity | 230 |
170 | Megistoquinone II | Anti-bacterial activity | 230 |
172 | 3-(2,3-Dihydroxy-3-methylbutyl)-4,7-dimethoxy-1-methyl-1H-quinolin-2-one | Anti-bacterial activity | 231 |
173 | Quinoline-4-carbaldehyde | Anti-bacterial activity | 232,233 |
Anti-fungal activity | 249 | ||
174 | 3-Methyl-2-(non-2enyl)quinolin-4(1H)-one | Anti-bacterial activity | 234,235 |
175 | 2-(2-Heptenyl)-3-methyl-4(lH)-quinolone | Anti-bacterial activity | 234,235 |
Anti-fungal activity | 249 | ||
176 | YM-30059 | Anti-bacterial activity | 236 |
177 | Aurachin A | Anti-bacterial activity | 237 |
Effect on cytochrome | 316,317 | ||
178 | Aurachin B | Anti-bacterial activity | 237 |
Effect on cytochrome | 316,317 | ||
179 | Aurachin C | Anti-bacterial activity | 237 |
Effect on cytochrome | 316,317 | ||
180 | Aurachin D | Anti-bacterial activity | 237 |
Effect on cytochrome | 316,317 | ||
181 | Helquinoline | Anti-bacterial activity | 238 |
182 | CJ-13136 | Anti-bacterial activity | 239 |
183 | CJ-13217 | Anti-bacterial activity | 239 |
184 | CJ-13536 | Anti-bacterial activity | 239 |
185 | (−)-CJ-13564 | Anti-bacterial activity | 239 |
186 | CJ-13565 | Anti-bacterial activity | 239 |
187 | CJ-13566 | Anti-bacterial activity | 239 |
188 | (+)-CJ-13567 | Anti-bacterial activity | 239 |
189 | (−)-CJ-13568 | Anti-bacterial activity | 239 |
190 | Sch 40832 | Anti-bacterial activity | 241 |
191 | 2-Heptylquinolin-4-ol | Anti-bacterial activity | 242 |
192 | 2-Pentylquinolin-4-ol | Anti-bacterial activity | 242 |
193 | trans-Decahydroquinoline 243A | Anti-bacterial activity | 243 |
194 | Anhydroevoxine | Anti-fungal activity | 244 |
195 | Platydesmine | Anti-fungal activity | 245 |
Anti-HIV activity | 284 | ||
196 | 1-Methyl-2-[6′-(3′′,4′′-methylenedioxyphenyl)hexyl]-4-quinolone | Anti-fungal activity | 247 |
197 | Distomadine B | Anti-fungal activity | 248 |
198 | Distomadine A | Anti-fungal activity | 248 |
199 | 4-Hydroxymethylquinoline | Anti-fungal activity | 249 |
200 | Quinoline-4-carbaldoxime | Anti-fungal activity | 249 |
201 | Quinoline-4-carboxylic acid | Anti-fungal activity | 249 |
202 | N-Mercapto-4-formylcarbostyril | Anti-fungal activity | 250 |
203 | Virantmycin | Anti-fungal activity | 251,252 |
Antiviral activity | 251,252 | ||
204 | Fumiquinazoline H | Anti-bacterial activity | 255 |
205 | Fumiquinazoline I | Anti-bacterial activity | 255 |
206 | Simulenoline | Antiplatelet activity | 95 |
207 | Benzosimuline | Antiplatelet activity | 95 |
208 | Zanthobungeanine | Antiplatelet activity | 95 |
209 | Robustine | Antiplatelet activity | 95 |
Cardiovascular protective activity | 275 | ||
210 | Edulitine | Antiplatelet activity | 95 |
211 | 4-Methoxy-1-methylquinolin-2-one | Antiplatelet activity | 268 |
Anti-HIV activity | 284 | ||
212 | Confusameline | Antiplatelet activity | 269–272 |
Cardiovascular protective activity | 275 | ||
Antagonists at the 5-HT2 receptor site | 307 | ||
213 | 1-Methoxyrutaecarpine | Antiplatelet activity | 277 |
214 | Acrophyllidine | Cardiovascular protective activity | 278 |
215 | Evodiamine | Anti-inflammatory activity | 297 |
Vasodilatory effect | 279 | ||
216 | Dehydroevodiamine | Vasodilatory effect | 279 |
217 | Uranidine | Anti-HIV activity | 282 |
218 | Buchapine | Anti-HIV activity | 283 |
219 | 3-Prenyl-4-prenyloxyquinolin-2-one | Anti-HIV activity | 283 |
220 | Sandramycin | Anti-HIV activity | 285 |
221 | Orixalone A | Anti-inflammatory activity | 294 |
222 | Quinolactacin A1 | Anti-inflammatory activity | 295,296 |
Anticholinesterase activity | 310 | ||
223 | Quinolactacin A1 | Anti-inflammatory activity | 295,296 |
Anticholinesterase activity | 310 | ||
224 | Quinolactacin B | Anti-inflammatory activity | 295,296 |
225 | Quinolactacin C | Anti-inflammatory activity | 295,296 |
226 | Isaindigotone | Anti-inflammatory activity | 304 |
227 | Quinazoline-2,4-dione | Anti-inflammatory activity | 305 |
Antihypertensive activity | 305 | ||
228 | Goshuyuamide II | Anti-inflammatory activity | 306 |
229 | Pteleprenine | Agonist of nicotinic acetylcholine receptors | 308 |
230 | Dictyoquinazol A | Cortical neurons protective activity | 312 |
231 | Dictyoquinazol B | Cortical neurons protective activity | 312 |
232 | Dictyoquinazol C | Cortical neurons protective activity | 312 |
233 | Fiscalin A | Inhibition of the binding of substance P | 313 |
234 | Fiscalin B | Inhibition of the binding of substance P | 313 |
235 | Fiscalin C | Inhibition of the binding of substance P | 313 |
236 | Circumdatin H | Effect on the respiratory chain | 324 |
237 | Circumdatin E | Effect on the respiratory chain | 324 |
238 | FR225659 | Hypoglycemic activity | 325–327 |
239 | 239 | Hypoglycemic activity | 325–327 |
240 | 240 | Hypoglycemic activity | 325–327 |
241 | 241 | Hypoglycemic activity | 325–327 |
242 | 242 | Hypoglycemic activity | 325–327 |
243 | 2,8-Dihydroxy-3,4-dimethoxyquinoline | Anti-oxidant activity | 329 |
244 | N-Methylflindersine | SRS-A antagonists | 333 |
245 | 2-Methyl-4(3H)-quinazolinone | Inhibitor of poly(ADP-ribose) synthetase | 338 |
246 | Eduline | Effect on muscle | 339 |
247 | Japonine | Effect on muscle | 339 |
Compounds 5–27 are CPT analogs and are not specifically listed in this table.